Cargando…
Letrozole supplementation during controlled ovarian stimulation in expected high responders: a pilot randomized controlled study
BACKGROUND: Almost all of the previous studies related with co-administration of letrozole in IVF cycles were performed in poor responders and letrozole may reduce the total gonadotropin dose required for ovarian stimulation, and the pregnancy rate did not decrease in poor responders. This study aim...
Autores principales: | Yang, Xiaoyi, Lin, Ge, Lu, Guangxiu, Gong, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511177/ https://www.ncbi.nlm.nih.gov/pubmed/31077214 http://dx.doi.org/10.1186/s12958-019-0483-x |
Ejemplares similares
-
Individualized controlled ovarian stimulation in expected poor-responders: an update
por: Haahr, Thor, et al.
Publicado: (2018) -
Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: A double-blind randomized clinical trial
por: Moini, Ashraf, et al.
Publicado: (2019) -
Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients
por: Sonigo, Charlotte, et al.
Publicado: (2019) -
Comparison of pregnancy outcome after letrozole versus clomiphene treatment for mild ovarian stimulation protocol in poor responders
por: Eftekhar, Maryam, et al.
Publicado: (2014) -
Letrozole+ GnRH antagonist stimulation protocol in poor ovarian responders undergoing intracytoplasmic sperm injection cycles: An RCT
por: Ebrahimi, Mahbod, et al.
Publicado: (2017)